Clincosm LogoSign in Get a demo

Non-Hodgkin Lymphoma

Showing NaN - NaN of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma Trial in Worldwide (Epcoritamab, Lenalidomide, Ibrutinib)

Recruiting
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +81 more
Jan 25, 2023

Non-Hodgkin Lymphoma, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in United States (radiation,

Recruiting
  • Non-Hodgkin Lymphoma
  • +2 more
  • Bridging radiotherapy (BRT)
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 24, 2023

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

Recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Duarte, California
  • +23 more
Dec 28, 2022

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Odronextamab multiple dose levels)

Recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Odronextamab multiple dose levels
  • Orange, California
  • +20 more
Dec 14, 2022

Non-Hodgkin Lymphoma Trial in United States (GDA-201)

Recruiting
  • Non-Hodgkin Lymphoma
  • Maywood, Illinois
  • +4 more
Nov 30, 2022

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Non-Hodgkin Lymphoma
    • Miami, Florida
    • +7 more
    Jun 23, 2022

    B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

    Recruiting
    • B-cell Malignancy
    • +3 more
    • CTX110
    • Los Angeles, California
    • +27 more
    May 6, 2022

    Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Multiple Myeloma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 4, 2022

    Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

    Recruiting
    • Lymphoma
    • +3 more
    • New York, New York
      Columbia University
    Apr 27, 2022

    Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-Hodgkin Lymphoma
    • B-cell Acute Lymphoblastic Leukemia
    • PBCAR0191
    • +2 more
    • Duarte, California
    • +9 more
    Apr 18, 2022

    Collecting and Storing Tissue Samples From Rare or Cutaneous

    Active, not recruiting
    • Adult Immunoblastic Lymphoma
    • +12 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +129 more
    Mar 23, 2022

    Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Goodyear, Arizona
    • +16 more
    Mar 18, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)

    Active, not recruiting
    • Multiple Myeloma
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 7, 2022

    Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

    Completed
    • Hodgkin Lymphoma
    • Non-hodgkin Lymphoma
    • AB-205
    • Duarte, California
    • +8 more
    Mar 1, 2022

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Tucson, Arizona
    • +9 more
    Feb 10, 2022

    Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

    Active, not recruiting
    • Acute Lymphoid Leukemia (ALL)
    • +5 more
    • Hyperfractionated total body irradiation
    • +9 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021